115 related articles for article (PubMed ID: 1751375)
1. A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpura.
Falanga A; Consonni R; Ruggenenti P; Barbui T
Br J Haematol; 1991 Nov; 79(3):474-80. PubMed ID: 1751375
[TBL] [Abstract][Full Text] [Related]
2. Further characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpura.
Consonni R; Falanga A; Barbui T
Br J Haematol; 1994 Jun; 87(2):321-4. PubMed ID: 7947274
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Moake JL; McPherson PD
Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
[TBL] [Abstract][Full Text] [Related]
5. Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura.
Murphy WG; Moore JC; Kelton JG
Blood; 1987 Nov; 70(5):1683-7. PubMed ID: 2822176
[TBL] [Abstract][Full Text] [Related]
6. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
7. The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS).
Moake JL
Prog Clin Biol Res; 1990; 337():135-40. PubMed ID: 2191307
[No Abstract] [Full Text] [Related]
8. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
Moore JC; Murphy WG; Kelton JG
Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of cysteine proteinase in thrombotic thrombocytopenic purpura.
Kelton JG; Moore JC; Warkentin TE; Hayward CP
Br J Haematol; 1996 May; 93(2):421-6. PubMed ID: 8639442
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
Byrnes JJ; Moake JL
Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
[TBL] [Abstract][Full Text] [Related]
11. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
[TBL] [Abstract][Full Text] [Related]
12. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
[TBL] [Abstract][Full Text] [Related]
13. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
Tsai HM; Rice L; Sarode R; Chow TW; Moake JL
Ann Intern Med; 2000 May; 132(10):794-9. PubMed ID: 10819702
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic thrombocytopenic purpura--a syndrome caused by multiple pathogenetic mechanisms.
Lian EC
Invest Clin; 2001 May; 42 Suppl 1():75-86. PubMed ID: 11416985
[TBL] [Abstract][Full Text] [Related]
15. Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma.
Lian EC; Harkness DR; Byrnes JJ; Wallach H; Nunez R
Blood; 1979 Feb; 53(2):333-8. PubMed ID: 570069
[TBL] [Abstract][Full Text] [Related]
16. Complete defect in vWF-cleaving protease activity associated with increased shear-induced platelet aggregation in thrombotic microangiopathy.
Ajzenberg N; Denis CV; Veyradier A; Girma JP; Meyer D; Baruch D
Thromb Haemost; 2002 May; 87(5):808-11. PubMed ID: 12038781
[TBL] [Abstract][Full Text] [Related]
17. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Furlan M
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
[TBL] [Abstract][Full Text] [Related]
18. Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura.
Furlan M; Lämmle B
Semin Thromb Hemost; 2002 Apr; 28(2):167-72. PubMed ID: 11992240
[TBL] [Abstract][Full Text] [Related]
19. The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo.
Mayr FB; Knöbl P; Jilma B; Siller-Matula JM; Wagner PG; Schaub RG; Gilbert JC; Jilma-Stohlawetz P
Transfusion; 2010 May; 50(5):1079-87. PubMed ID: 20070617
[TBL] [Abstract][Full Text] [Related]
20. Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome.
Katayama M; Handa M; Araki Y; Ambo H; Kawai Y; Watanabe K; Ikeda Y
Br J Haematol; 1993 Aug; 84(4):702-10. PubMed ID: 7692937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]